Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- CGM as medicine: Technology benefits extend to type 2 diabetes Regina Schaffer
-
- ACROSTUDY: Pegvisomant safe, effective for long-term use in acromegaly Regina Schaffer
- Authorized generic drugs ‘insufficient’ to improve affordability in Medicare Part D Regina Schaffer
- Dentists, orthodontists play key role in recognizing facial manifestations of acromegaly Regina Schaffer
- Education, transition support needed for effective diabetes management after incarceration Regina Schaffer
- Evaluate both fracture, mortality risks to inform osteoporosis treatment for older men Michael Monostra
- Express Scripts to prefer first interchangeable biosimilar insulin Regina Schaffer
- Finerenone plus SGLT2 inhibition may yield additive CV, kidney benefits: FIGARO-DKD Regina Schaffer
- Fracture risks, benefits vary with different diabetes drugs Regina Schaffer
-
- Hip fracture hospitalizations down 11% during first COVID-19 lockdown Michael Monostra
- Increased cancer risk observed decades after radioactive iodine treatment Regina Schaffer
- Know the rules regarding COVID-19 vaccine mandates for health care workers Jonathan D. Leffert, MD, FACP, FACE, ECNU
- Menopause-related sleep disturbances influence mood, metabolism Regina Schaffer
- Midlife migraines ‘treatable,’ but team-based approach needed Regina Schaffer
- Mortality after bariatric surgery ‘remarkably worse’ for men than women Michael Monostra
- Nonhormonal therapy reduces moderate to severe menopausal hot flashes Regina Schaffer
- Novel once-weekly basal insulin safe, effective in type 2 diabetes Regina Schaffer
-
- Proposed guideline focuses on individualized approach for thyroid eye disease Michael Monostra
- Treatment of thyroid eye disease varies between North American, European providers Michael Monostra
- VIDEO: Obesity increases risks for long-term COVID-19 symptoms Sangeeta Kashyap, MD
- Proposed FRAX multipliers overestimate fracture risk for women with recent fracture Michael Monostra
- Do the benefits of CGM justify the current cost in type 2 diabetes care? Regina Schaffer